Cargando…
IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness o...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955658/ https://www.ncbi.nlm.nih.gov/pubmed/20875119 http://dx.doi.org/10.1186/1471-2288-10-85 |
_version_ | 1782188061797384192 |
---|---|
author | Oude Rengerink, Katrien Opmeer, Brent C Logtenberg, Sabine LM Hooft, Lotty Bloemenkamp, Kitty WM Haak, Monique C Oudijk, Martijn A Spaanderman, Marc E Duvekot, Johannes J Willekes, Christine van Pampus, Maria G Porath, Martina M van Eyck, Jim Sikkema, Marko J Mol, Ben Willem J |
author_facet | Oude Rengerink, Katrien Opmeer, Brent C Logtenberg, Sabine LM Hooft, Lotty Bloemenkamp, Kitty WM Haak, Monique C Oudijk, Martijn A Spaanderman, Marc E Duvekot, Johannes J Willekes, Christine van Pampus, Maria G Porath, Martina M van Eyck, Jim Sikkema, Marko J Mol, Ben Willem J |
author_sort | Oude Rengerink, Katrien |
collection | PubMed |
description | BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies. METHODS/DESIGN: We will perform two cohort studies and a case-control study in the Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants - aggregated at centre level - for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time. DISCUSSION: This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials. |
format | Text |
id | pubmed-2955658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29556582010-10-16 IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT Oude Rengerink, Katrien Opmeer, Brent C Logtenberg, Sabine LM Hooft, Lotty Bloemenkamp, Kitty WM Haak, Monique C Oudijk, Martijn A Spaanderman, Marc E Duvekot, Johannes J Willekes, Christine van Pampus, Maria G Porath, Martina M van Eyck, Jim Sikkema, Marko J Mol, Ben Willem J BMC Med Res Methodol Study Protocol BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies. METHODS/DESIGN: We will perform two cohort studies and a case-control study in the Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants - aggregated at centre level - for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time. DISCUSSION: This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials. BioMed Central 2010-09-27 /pmc/articles/PMC2955658/ /pubmed/20875119 http://dx.doi.org/10.1186/1471-2288-10-85 Text en Copyright ©2010 Oude Rengerink et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Oude Rengerink, Katrien Opmeer, Brent C Logtenberg, Sabine LM Hooft, Lotty Bloemenkamp, Kitty WM Haak, Monique C Oudijk, Martijn A Spaanderman, Marc E Duvekot, Johannes J Willekes, Christine van Pampus, Maria G Porath, Martina M van Eyck, Jim Sikkema, Marko J Mol, Ben Willem J IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title | IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title_full | IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title_fullStr | IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title_full_unstemmed | IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title_short | IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT |
title_sort | improving participation of patients in clinical trials - rationale and design of impact |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955658/ https://www.ncbi.nlm.nih.gov/pubmed/20875119 http://dx.doi.org/10.1186/1471-2288-10-85 |
work_keys_str_mv | AT ouderengerinkkatrien improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT opmeerbrentc improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT logtenbergsabinelm improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT hooftlotty improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT bloemenkampkittywm improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT haakmoniquec improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT oudijkmartijna improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT spaandermanmarce improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT duvekotjohannesj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT willekeschristine improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT vanpampusmariag improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT porathmartinam improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT vaneyckjim improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT sikkemamarkoj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact AT molbenwillemj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact |